| Q64255883 | 3,5-Diiodo-L-Thyronine Exerts Metabolically Favorable Effects on Visceral Adipose Tissue of Rats Receiving a High-Fat Diet |
| Q54528275 | A microarray analysis of the hypoxia-induced modulation of gene expression in human adipocytes. |
| Q33356605 | A vascular piece in the puzzle of adipose tissue dysfunction: mechanisms and consequences |
| Q39404153 | A vicious circle in chronic lymphoedema pathophysiology? An adipocentric view. |
| Q36966839 | AMPK, insulin resistance, and the metabolic syndrome |
| Q55030703 | Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans. |
| Q38030832 | Adaptive immunity in obesity and insulin resistance |
| Q36481128 | Adipocyte-Specific Hypoxia-Inducible Factor 2α Deficiency Exacerbates Obesity-Induced Brown Adipose Tissue Dysfunction and Metabolic Dysregulation |
| Q36933370 | Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine. |
| Q37707281 | Adipokines: a link between obesity and cardiovascular disease. |
| Q46355670 | Adipose Tissue Hypoxia in Obesity and Its Impact on Preadipocytes and Macrophages: Hypoxia Hypothesis |
| Q37352210 | Adipose tissue angiogenesis: impact on obesity and type-2 diabetes |
| Q50199937 | Adipose tissue autophagy related gene expression is associated with glucometabolic status in human obesity |
| Q38474612 | Adipose tissue dysfunction and impaired metabolic health in human obesity: a matter of oxygen? |
| Q37036130 | Adipose tissue fibrosis, hypertrophy, and hyperplasia: Correlations with diabetes in human obesity. |
| Q26768692 | Adipose tissue macrophages: going off track during obesity |
| Q37568276 | Adipose tissue oxygenation: Effects on metabolic function |
| Q51499251 | Adipose-derived stem cells sustain prolonged angiogenesis through leptin secretion. |
| Q47221740 | Aerobic Training Improves Angiogenic Potential Independently of Vascular Endothelial Growth Factor Modifications in Postmenopausal Women. |
| Q48256654 | Aerobic exercise elevates markers of angiogenesis and macrophage IL-6 gene expression in the subcutaneous adipose tissue of overweight-to-obese adults. |
| Q34244804 | Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesity |
| Q35663004 | BOLD-MRI evaluation of subcutaneous and visceral adipose tissue oxygenation status: effect of dietary salt intake |
| Q42712221 | Characterization of the inflammatory and metabolic profile of adipose tissue in a mouse model of chronic hypoxia |
| Q90482420 | Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus |
| Q34073826 | Control of adipose tissue expandability in response to high fat diet by the insulin-like growth factor-binding protein-4 |
| Q42122618 | Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea |
| Q37736462 | Cultured 3T3L1 adipocytes dispose of excess medium glucose as lactate under abundant oxygen availability. |
| Q91641888 | Delayed insulin absorption correlates with alterations in subcutaneous depot kinetics in rats with diet-induced obesity |
| Q38089671 | Diabetes mellitus and inflammation |
| Q45072634 | Diabetic Microvascular Disease: An Endocrine Society Scientific Statement |
| Q47236459 | Diet-induced weight loss decreases adipose tissue oxygen tension with parallel changes in adipose tissue phenotype and insulin sensitivity in overweight humans. |
| Q36719115 | Differentiation of human adipocytes at physiological oxygen levels results in increased adiponectin secretion and isoproterenol-stimulated lipolysis |
| Q35992769 | Diffuse optical spectroscopic imaging of subcutaneous adipose tissue metabolic changes during weight loss |
| Q41870047 | Diffusion and perfusion: the keys to fat grafting |
| Q37669778 | Does bariatric surgery improve adipose tissue function? |
| Q36546851 | Effect of rosiglitazone on capillary density and angiogenesis in adipose tissue of normoglycaemic humans in a randomised controlled trial |
| Q26772288 | Effects of Hyperoxia on Oxygen-Related Inflammation with a Focus on Obesity |
| Q42012692 | Effects of Hypoxia on the Immunomodulatory Properties of Adipose Tissue-Derived Mesenchymal Stem cells |
| Q38089637 | Effects of exercise training on chronic inflammation in obesity : current evidence and potential mechanisms |
| Q42405839 | Effects of hypoxia on proliferation of human cord blood-derived mesenchymal stem cells |
| Q55091926 | Elevated and Correlated Expressions of miR-24, miR-30d, miR-146a, and SFRP-4 in Human Abdominal Adipose Tissue Play a Role in Adiposity and Insulin Resistance. |
| Q46355665 | Endothelial Dysfunction in Obesity |
| Q90461405 | Extracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases |
| Q57029307 | Fat fibrosis: friend or foe? |
| Q37227722 | Fibrosis and adipose tissue dysfunction |
| Q47950561 | Function and Dysfunction of Adipose Tissue |
| Q38072900 | Hypoxia and adipose tissue function and dysfunction in obesity. |
| Q40581636 | Hypoxia and extra-cellular matrix gene expression in adipose tissue associates with reduced insulin sensitivity in black South African women. |
| Q38728642 | Hypoxia in Obesity and Diabetes: Potential Therapeutic Effects of Hyperoxia and Nitrate. |
| Q37671425 | Hypoxia induces a HIF-1α dependent signaling cascade to make a complex metabolic switch in SGBS-adipocytes |
| Q26861253 | Hypoxia, Oxidative Stress and Fat |
| Q40369825 | Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice. |
| Q30251565 | Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease |
| Q47173749 | Hypoxia: a consequence of obesity and also a tool to treat excessive weight loss |
| Q47977512 | Impact of intermittent hypoxia and exercise on blood pressure and metabolic features from obese subjects suffering sleep apnea-hypopnea syndrome |
| Q41189742 | Insights into an adipocyte whitening program |
| Q64091126 | Insulin Controls Triacylglycerol Synthesis through Control of Glycerol Metabolism and Despite Increased Lipogenesis |
| Q84916971 | Lactate and the GPR81 receptor in metabolic regulation: implications for adipose tissue function and fatty acid utilisation by muscle during exercise |
| Q99561825 | Leptin: Master Regulator of Biological Functions that Affects Breathing |
| Q47713193 | Low Oxygen Consumption is Related to a Hypomethylation and an Increased Secretion of IL-6 in Obese Subjects with Sleep Apnea-Hypopnea Syndrome |
| Q91100250 | Mechanisms of weight regain after weight loss - the role of adipose tissue |
| Q35780714 | Metabolic characteristics of human subcutaneous abdominal adipose tissue after overnight fast |
| Q30991322 | Metabolic imaging in obesity: underlying mechanisms and consequences in the whole body |
| Q36795988 | Metabolic signatures of human adipose tissue hypoxia in obesity |
| Q90121101 | Metabolically healthy obesity: facts and fantasies |
| Q33687365 | Methylglyoxal-induced glycation changes adipose tissue vascular architecture, flow and expansion, leading to insulin resistance. |
| Q92993311 | Mitochondrial Dysfunction in Adipocytes as a Primary Cause of Adipose Tissue Inflammation |
| Q38172822 | Morphological and inflammatory changes in visceral adipose tissue during obesity. |
| Q26823676 | Multiple adipose depots increase cardiovascular risk via local and systemic effects |
| Q26775794 | Neuroinflammation and comorbidities are frequently ignored factors in CNS pathology |
| Q51312447 | Non-Invasive Ventilation (NIV) and Homeostatic Model Assessment (HOMA) Index in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients with Chronic Hypercapnic Respiratory Failure: A Pilot Study. |
| Q47970360 | Nordic walking increases circulating VEGF more than traditional walking training in postmenopause. |
| Q36703016 | Obesity Determines the Immunophenotypic Profile and Functional Characteristics of Human Mesenchymal Stem Cells From Adipose Tissue. |
| Q42005589 | Obesity as a Conditioning Factor for High-Altitude Diseases |
| Q36951691 | Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. |
| Q35099545 | Oxygen deprivation and the cellular response to hypoxia in adipocytes - perspectives on white and brown adipose tissues in obesity |
| Q91939988 | Oxygenation of adipose tissue: A human perspective |
| Q38133593 | Persistent organic pollutants meet adipose tissue hypoxia: does cross-talk contribute to inflammation during obesity? |
| Q36653987 | Reduced flow-and acetylcholine-induced dilations in visceral compared to subcutaneous adipose arterioles in human morbid obesity |
| Q38156042 | Regulation of human subcutaneous adipose tissue blood flow |
| Q38989143 | Regulation of obesity and insulin resistance by hypoxia-inducible factors |
| Q64115395 | Relevance of Oxygen Concentration in Stem Cell Culture for Regenerative Medicine |
| Q42921151 | Response to comment on Lecoultre et al. Ten nights of moderate hypoxia improves insulin sensitivity in obese humans. Diabetes care 2013;36:e197-e198. |
| Q38668014 | Role of Epicardial Adipose Tissue in Health and Disease: A Matter of Fat? |
| Q28080292 | Role of neuroinflammation in neurodegenerative diseases (Review) |
| Q89518644 | Stratifying cellular metabolism during weight loss: an interplay of metabolism, metabolic flexibility and inflammation |
| Q36208137 | Targeting adipose tissue angiogenesis to enhance insulin sensitivity |
| Q38548027 | Targeting fatty acid metabolism to improve glucose metabolism. |
| Q43083658 | Tensions rise and blood flows over dysfunctional fat. |
| Q28076823 | The Circulatory and Metabolic Responses to Hypoxia in Humans - With Special Reference to Adipose Tissue Physiology and Obesity |
| Q26780509 | The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease |
| Q38410928 | The Hypoxia-Inducible Factor Pathway in Adipocytes: The Role of HIF-2 in Adipose Inflammation and Hypertrophic Cardiomyopathy |
| Q42024131 | The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function |
| Q43633983 | The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men. |
| Q59607787 | The effects of polyphenol supplementation on adipose tissue morphology and gene expression in overweight and obese humans |
| Q49430910 | The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis |
| Q38044215 | The renin-angiotensin system in the pathophysiology of type 2 diabetes |
| Q89662533 | Through fat and thin - a journey with the adipose tissues |
| Q40266576 | Transepidermal oxygen flux measurement - First clinical application for postoperative wound monitoring |
| Q36436838 | Transient hypoxia reprograms differentiating adipocytes for enhanced insulin sensitivity and triglyceride accumulation |
| Q38490628 | Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition |
| Q37982682 | Update on adipose tissue blood flow regulation |
| Q54978325 | Upregulation of angiostatic chemokines IP-10/CXCL10 and I-TAC/CXCL11 in human obesity and their implication for adipose tissue angiogenesis. |
| Q28727779 | Valsartan improves adipose tissue function in humans with impaired glucose metabolism: a randomized placebo-controlled double-blind trial |
| Q37726638 | Vascular rarefaction mediates whitening of brown fat in obesity. |
| Q47772610 | Visceral White Adipose Tissue after Chronic Intermittent and Sustained Hypoxia in Mice. |
| Q35642563 | Visceral adiposopathy: a vascular perspective |
| Q33684984 | What causes the insulin resistance underlying obesity? |
| Q27686959 | What distinguishes adipose tissue of severely obese humans who are insulin sensitive and resistant? |
| Q64986896 | White Adipose Tissue Response of Obese Mice to Ambient Oxygen Restriction at Thermoneutrality: Response Markers Identified, but no WAT Inflammation. |